Scripps Research Institute | GenomeWeb

Scripps Research Institute

The partners will work together to adapt a new chemical synthesis technology for DNA-encoded library creation.

Together, Forever

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

Scripps Research Institute, La Jolla, California, aerial view

The institute has also been awarded additional funding from the National Institutes of Health for its increased participation in the initiative.

Scientists led by the Scripps Research Institute's Benjamin Cravatt have developed probes and a mass spec method to find methyltransferases in human cells.

Scripps' Gerald Joyce and David Horning have created an RNA polymerase that can replicate short RNA templates faster and create more complex RNA structures than ever before.

The Human Immunome Program, which is part of the Human Vaccines Project, eventually plans to profile B-cell and T-cell receptors in more than 1,000 individuals.

Over the next half year, iGenomX plans to roll out its sequencing library prep chemistry for linked read sequencing.

An analysis of samples taken a year after kidney transplant identified overlapping gene expression signatures associated with acute and chronic rejection.

Heating Dispute

A paper finds that heating in gas chromatography-mass spectrometry analysis may alter sample compounds, drawing criticism.

The partners will continue to develop and collaborate on the PluriTest software to improve the quality control of human induced pluripotent stem cell lines.

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.